Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

BGI collaborates with Covaris for next generation sequencing technology

Beijing Genomics Institute (BGI) has entered into a partnership to integrate Covaris' Adaptive Focused Acoustics (AFA) DNA shearing technology across several of its laboratories in China.

BGI will use Covaris’ LE220 parallel processing, multi-sample platform to fragment DNA samples for next-generation sequencing.

Covaris claims its AFA technology improves recoveries, increases efficiency, and provides high-quality reproducible DNA shearing results.

Wu of BGI said the Covaris LE220 instrument offers both high-throughput capability and high-quality results for their downstream applications.

Covaris president and CEO Jim Laugharn said the Covaris systems set the standard for advancing analytical technologies and sophisticated assays.

"Isothermal Covaris processes will be beneficial for proteomic-related studies such as ChIP," Laugharn said.